假单胞菌病中的型特异性免疫。 - Suppr

Suppr

超能文献

Type-specific immunity in pseudomonas diseases.

作者信息

Crowder J G, Fisher M W, White A

出版信息

J Lab Clin Med. 1972 Jan;79(1):47-54.

PMID:4621414

Abstract

摘要

相似文献

Type-specific immunity in pseudomonas diseases.

J Lab Clin Med. 1972 Jan;79(1):47-54.

Clinical evaluation of Pseudomonas hyperimmune globulin and plasma.

Surg Forum. 1970;21:238-40.

Pseudomonas endocarditis: hemagglutinating antibodies to Fisher-Devlin-Gnabasik immunotypes in sera.

J Lab Clin Med. 1974 Jun;83(6):845-52.

Role of antibody in infections due to Pseudomonas aeruginosa.

J Infect Dis. 1974 Nov;130 Suppl(0):S111-8. doi: 10.1093/infdis/130.supplement.s111.

Passive protective properties of serum fractions from mice inoculated with an anti-pseudomonas vaccine.

Immunology. 1972 Dec;23(6):889-95.

Specificity of the protective response induced by the slime layer of Pseudomonas aeruginosa.

J Hyg (Lond). 1974 Aug;73(1):75-84. doi: 10.1017/s002217240002386x.

Bacterial blocking activity of specific IgG in chronic Pseudomonas aeruginosa infection.

Clin Exp Immunol. 1975 Jan;19(1):121-30.

Protection against Pseudomonas aeruginosa infection by immunisation with fractions of culture filtrates of Ps. aeruginosa.

Br J Exp Pathol. 1968 Oct;49(5):411-20.

[Hemagglutination reactions of tanned red cells with Pseudomonas aeruginosa extract as the antigen--preliminary observation on the serum of patients with chronic otitis media].

Nihon Saikingaku Zasshi. 1971 Oct;26(10):467-72.

Human immunity to Pseudomonas aeruginosa. II. Relationship between heat-stable opsonins and type-specific lipopolysaccharides.

J Infect Dis. 1972 Sep;126(3):277-87. doi: 10.1093/infdis/126.3.277.

引用本文的文献

Recent developments for Pseudomonas vaccines.

Hum Vaccin. 2011 Oct;7(10):999-1011. doi: 10.4161/hv.7.10.16369. Epub 2011 Oct 1.

Pseudomonas aeruginosa lipopolysaccharide: a major virulence factor, initiator of inflammation and target for effective immunity.

Int J Med Microbiol. 2007 Sep;297(5):277-95. doi: 10.1016/j.ijmm.2007.03.012. Epub 2007 Apr 27.

Safety and immunogenicity of high molecular weight polysaccharide vaccine from immunotype 1 Pseudomonas aeruginosa.

J Clin Invest. 1982 Feb;69(2):303-8. doi: 10.1172/jci110453.

Active immunization with lipopolysaccharide Pseudomonas antigen for chronic Pseudomonas bronchopneumonia in guinea pigs.

J Clin Invest. 1981 Nov;68(5):1140-8. doi: 10.1172/jci110358.

Protection against Pseudomonas aeruginosa infection in a murine burn wound sepsis model by passive transfer of antitoxin A, antielastase, and antilipopolysaccharide.

Infect Immun. 1983 Mar;39(3):1072-9. doi: 10.1128/iai.39.3.1072-1079.1983.

High-molecular-weight polysaccharide antigen from Pseudomonas aeruginosa immunotype 2.

Infect Immun. 1981 Nov;34(2):461-8. doi: 10.1128/iai.34.2.461-468.1981.

Development of cellular and humoral immunity in the respiratory tract of rabbits to Pseudomonas lipopolysaccharide.

J Clin Invest. 1974 May;53(5):1351-8. doi: 10.1172/JCI107683.

Evaluation of three serological tests for detection of antibody to Pseudomonas aeruginosa in human sera.

Eur J Clin Microbiol. 1985 Apr;4(2):190-6. doi: 10.1007/BF02013596.

Protection against fatal Pseudomonas aeruginosa sepsis by immunization with smooth and rough lipopolysaccharides.

Eur J Clin Microbiol. 1985 Apr;4(2):180-5. doi: 10.1007/BF02013594.

Structural analysis and immunogenicity of Pseudomonas aeruginosa immunotype 2 high molecular weight polysaccharide.

J Clin Invest. 1986 Feb;77(2):491-5. doi: 10.1172/JCI112328.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验